Progress in drug treatment of chronic thromboembolic pulmonary hypertensionGUO Wen-liang, HONG Cheng5-9
Surgical treatment of chronic thromboembolic pulmonary hypertensionLIU Xiao-peng, ZHEN Ya-nan10-13,27
Perioperative anaesthetic management of patients with chronic thromboembolic pulmonary hypertensionZHANG Ya-jun14-19
Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertensionHUANG Qiang, WANG Jian-feng20-23
Anticoagulant therapy for chronic thromboembolic pulmonary hypertensionGONG Su-gang, ZHAO Qin-hua, WANG Lan24-27
Updated diagnosis and classification of WHO myeloproliferative neoplasms(MPN)and myelodysplastic/myeloproliferative neoplasms(MDS/MPN)in 2022GONG Yue-min, LI Yue, HE Guang-sheng28-31
Expert opinion on glucagon-like peptide-1 receptor agonist for treatment of type 2 diabetes in primary health carePanel of glucagon-like peptide-1 receptor agonist for treatment of type 2 diabetes in primary health care32-38
Clinical features of anemia in minimal change disease and focal segmental glomerulosclerosis patientsLI Zhe, TU Yuan-mao, ZHU Shu-hua, ZUO Ke, LE Wei-bo, ZHANG Hai-tao, WANG Xia39-44,51
Establishment and validation of an immune-related gene model to predict rectum adenocarcinoma prognosisSUN Chen-rui, XIAO Qiong, FU Yu, LI Meng-han, GAO Peng, SONG Yong-xi45-51